Health Care(IN00392.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Health Care
IN00392.US
News
View More

Insider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) CAO Sells $19,371.87 in Stock

Apellis Pharmaceuticals' CAO, James George Chopas, sold 873 shares at $22.19 each, totaling $19,371.87, reducing his ownership by 1.63% to 52,595 shares valued at approximately $1.17 million. The transaction was disclosed to the SEC. The stock recently traded at $20.53, with a market cap of $2.60 billion and a P/E ratio of 66.23. Analysts have varied target prices, with Citigroup lowering theirs from $52 to $45, while Wells Fargo set a target of $32. Institutional investors hold 96.29% of the stock.

Market Beat·
US
APLS
+0.98%
Market Beat·
US
APLS
+0.98%

Acrivon Therapeutics (NASDAQ:ACRV) COO Purchases $17,200.00 in Stock

Acrivon Therapeutics COO Eric Devroe purchased 10,000 shares of the company's stock at $1.72 per share, totaling $17,200. This acquisition increased his holdings to 75,308 shares, valued at approximately $129,529.76, marking a 15.31% increase in his position. The transaction was disclosed to the SEC. Acrivon Therapeutics shares traded at $1.87, with a market cap of $59.02 million. Analysts have mixed ratings on the stock, with a consensus price target of $11.67.

Market Beat·
US
ACRV
+2.19%
Market Beat·
US
ACRV
+2.19%

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Charles River Laboratories International Inc. (CRL) shares rose 3.27% to $223.47 on a strong trading day, outperforming competitors like Labcorp Holdings Inc. (LH) and Bio-Techne Corp. (TECH). The S&P 500 Index increased by 0.26%, while the Dow Jones Industrial Average rose by 0.60%. CRL's stock is 2.36% below its 52-week high of $228.88, reached on January 13th. Trading volume was 779,526, below the 50-day average of 876,962.

Dow Jones·
US
CRL
+3.27%
Dow Jones·
US
CRL
+3.27%

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Bio-Techne Corp. (TECH) shares rose 3.07% to $68.40 on a challenging trading day for the market, with the S&P 500 down 0.53%. The stock remains 13.72% below its 52-week high of $79.28. Competitors had mixed results, with Amgen up 1.44%, Charles River down 1.19%, and BioMarin up 1.59%. Trading volume reached 2.7 million, surpassing the 50-day average of 1.9 million.

Dow Jones·
US
TECH
+2.28%
Dow Jones·
US
TECH
+2.28%

Align Technology Inc. Stock Outperforms Competitors On Strong Trading Day

Align Technology Inc. (ALGN) shares rose 1.32% to $171.47 on a strong trading day, breaking a three-day losing streak. The S&P 500 Index increased by 0.26%, while the Dow Jones Industrial Average rose by 0.60%. Despite the gain, Align's stock remains 27.72% below its 52-week high of $237.23. Competitors showed mixed results, with Zimmer Biomet Holdings Inc. down 0.55% and Dentsply Sirona Inc. up 1.86%. Trading volume was below the 50-day average.

Dow Jones·
US
ALGN
+1.32%
Dow Jones·
US
ALGN
+1.32%
Posts
View More

$Grab(GRAB.US) trading as if Singapore is about to get invaded 😂😂😂😂

in all seriousness, yes it sucks to be stuck in something that isn’t moving and was just up 35% a few months ago, but it also beg...........................

$Unitedhealth(UNH.US) anyone same like me? speechless after watching this...

$Unitedhealth(UNH.US) Because people need healthcare in good times and bad. It's not a cyclical growth story, it's a steady compounder

$Unitedhealth(UNH.US) A core holding for risk reduction👍

Added some $Novo Nordisk AS(NVO.US) in the night session

I've been feeling the position was too small these days, so I topped up this time. Now just be patient and let time do its work!

 

Not investment ...

© 2026 Longbridge｜Disclaimer